Finasteride Cost in Iowa 2026: Cash Pay, Insurance, and Compounded Options

What Finasteride Actually Costs in Iowa Right Now

Generic finasteride is one of the most affordable prescription medications available in Iowa in 2026. A 30-day supply of 1 mg tablets runs approximately $12 at major Iowa retail chains, including CVS, Hy-Vee Pharmacy, and Walgreens, when a GoodRx or similar discount card is applied at checkout. Without any discount card, the same generic supply averages $18 to $25 depending on the pharmacy. Merck's branded Propecia carries a list price near $85 per month, but almost no cash-pay patient purchases at list price given how widely available generic substitutes are.

The 5 mg dose used for benign prostatic hyperplasia (BPH) costs similarly. Generic finasteride 5 mg (the equivalent of Proscar) runs $15 to $30 per month cash-pay at Iowa pharmacies, making it one of the cheapest BPH medications on the market. The FDA first approved finasteride 5 mg (Proscar) in 1992 for BPH and 1 mg (Propecia) in 1997 for androgenetic alopecia, and the patents expired years ago, allowing generic competition to drive prices down substantially. Details on FDA-approved labeling are available at the FDA's drug database.

Price varies by quantity dispensed. Requesting a 90-day supply instead of 30 days routinely lowers the per-tablet cost by 10 to 20 percent at most Iowa pharmacies. Some patients who take the 5 mg tablet for hair loss split it into five 1 mg portions, a practice sometimes called "pill splitting," which can bring the monthly cost below $6. This off-label splitting should be discussed with the prescribing clinician before attempting, since tablet coatings and extended-release formulations should not be split. Finasteride immediate-release tablets are generally safe to split, but your pharmacist can confirm the specific product. The FDA's guidance on drug pricing and generics provides context on how generic pricing works nationally.

The table below summarizes the three main pricing tiers an Iowa resident will encounter in 2026.

| Route | Monthly Cost (Approx.) | Notes | |---|---|---| | Generic retail, cash-pay with discount card | $12 | Widely available; no insurance needed | | Compounded 503A pharmacy | $45 | Includes formulation fee; may include shipping | | Brand Propecia (Merck) | $85 | List price; rarely paid out-of-pocket |

How Iowa Medicaid Handles Finasteride

Iowa Medicaid does not cover finasteride for androgenetic alopecia (male or female pattern hair loss). Hair loss is classified as a cosmetic condition under Iowa Medicaid's Preferred Drug List (PDL) guidelines, placing it outside covered benefits regardless of clinical severity. This aligns with Medicaid policies in most states, which generally exclude cosmetic drug indications. The Centers for Medicare and Medicaid Services provides the regulatory framework governing state Medicaid drug coverage.

BPH is a different story. Iowa Medicaid does cover finasteride 5 mg for BPH as a medically necessary treatment, though it requires prior authorization in some managed care organization (MCO) formularies. Iowa's Medicaid program is administered through three MCOs: Iowa Total Care, Molina Healthcare of Iowa, and AmeriHealth Caritas Iowa. Each MCO maintains its own PDL, so coverage details differ. Calling member services before filling a prescription saves time and avoids surprise rejections at the pharmacy counter.

Iowa Medicaid's fee-for-service program, which covers members not yet enrolled in an MCO, lists finasteride 5 mg as a covered drug for BPH diagnoses. The current Iowa Medicaid PDL is published by the Iowa Department of Health and Human Services and can be verified online. The Iowa DHHS Medicaid page is the primary state source for current formulary information.

Medicare Part D plans operating in Iowa follow CMS guidelines that exclude drugs used for cosmetic purposes, meaning finasteride for hair loss is not covered under Part D either. For BPH, most Part D plans do include finasteride 5 mg, typically in Tier 1 or Tier 2, with a copay of $0 to $10 per month in the coverage phase.

Commercial Insurance Coverage for Finasteride in Iowa

Most major commercial insurers operating in Iowa cover finasteride 5 mg for BPH. Coverage for 1 mg finasteride for AGA is inconsistent and often denied. The plans below represent the most common commercial carriers in Iowa and their general approach to finasteride coverage as of 2026.

Wellmark Blue Cross Blue Shield of Iowa. Iowa's largest commercial insurer covers finasteride 5 mg for BPH on most employer group plans, typically at Tier 1 (generic) with a $5 to $15 copay. Coverage for 1 mg finasteride depends on individual plan design; many employer-sponsored plans exclude it under cosmetic drug exclusions.

UnitedHealthcare. UHC Iowa plans generally cover finasteride 5 mg for BPH without prior authorization. Hair loss indication coverage varies. Members should check their Summary of Benefits and Coverage document or call the number on their insurance card before assuming coverage.

Aetna and Cigna Iowa plans follow similar patterns. Generic finasteride for BPH is typically covered. Aetna's clinical policy bulletin on AGA has historically classified topical and oral hair loss treatments as cosmetic and therefore not covered. Aetna's national coverage policies are informed by clinical evidence including trial-level data such as Kaufman et al.

Prior authorization requirements are the most common barrier. When a prescriber submits a PA for finasteride for AGA, the insurer usually requests documentation showing the cosmetic indication, which is sufficient grounds for denial under most plan documents. For BPH, PA is less common but still required by some MCOs and high-deductible plans.

If insurance denies coverage for finasteride for hair loss, the out-of-pocket cash-pay price of $12 per month is typically lower than most specialist copays, making the insurance appeal process less financially urgent than it might be for higher-cost drugs.

Is Compounded Finasteride Legal in Iowa?

Yes. Compounded finasteride is legal in Iowa when prepared by a state-licensed 503A compounding pharmacy. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies that prepare medications for individual patients based on a valid prescription from a licensed prescriber. Iowa pharmacy law, administered by the Iowa Board of Pharmacy, permits 503A compounding of finasteride in oral, topical, and other dosage forms for individual patients. The FDA's overview of the 503A compounding framework describes the federal regulatory standards that Iowa pharmacies must also meet.

503B outsourcing facilities, which produce larger batches for distribution without patient-specific prescriptions, operate under stricter FDA oversight. Compounded finasteride from a 503B facility is less commonly prescribed for hair loss but is used in some clinical settings for BPH. Iowa patients receiving compounded finasteride from telehealth platforms should confirm whether the compounding partner is a 503A or 503B facility, since the regulatory status affects how the product may be distributed.

Common compounded formulations available in Iowa include oral capsules (alternative to the commercial tablet) and topical solutions (finasteride in a minoxidil base, sometimes called a "combo topical"). Topical finasteride has attracted research interest because it may reduce systemic absorption. A 2018 study published in the Journal of the American Academy of Dermatology evaluated topical finasteride 0.25% and found it produced meaningful hair count increases with lower plasma DHT suppression than oral dosing. That study is indexed at PubMed.

Compounded finasteride in Iowa runs approximately $45 per month, reflecting the pharmacy's formulation fee, ingredient cost, and, for telehealth-ordered prescriptions, shipping. This is higher than generic retail finasteride but may be justified for patients who prefer a topical formulation or a specific dose not commercially available.

Clinical Efficacy: What the Evidence Says

Finasteride works by selectively inhibiting type II 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). DHT is the androgen primarily responsible for follicular miniaturization in androgenetic alopecia and for prostate cell proliferation in BPH. Oral finasteride 1 mg reduces scalp DHT by approximately 64% and serum DHT by approximately 68%. The mechanism and pharmacodynamic data are documented in the FDA-approved prescribing information.

The landmark trial establishing finasteride's efficacy for AGA is Kaufman et al. (1998), published in the Journal of the American Academy of Dermatology. In that randomized, placebo-controlled trial of men with vertex and anterior mid-scalp hair loss, finasteride 1 mg daily for 2 years produced a 48% increase in hair count at the vertex scalp compared with baseline. Placebo-treated men lost hair over the same period. Hair growth was maintained through 5 years of follow-up in separate extension data. The Kaufman et al. study is available at PubMed PMID 9777765.

For BPH, finasteride 5 mg produces clinically meaningful reductions in prostate volume and urinary symptom scores. The PLESS trial (Proscar Long-Term Efficacy and Safety Study) followed 3,040 men over 4 years. Finasteride reduced prostate volume by 18% on average and cut the risk of acute urinary retention by 57% compared with placebo. The PLESS trial data are summarized in publications indexed at PubMed.

The American Urological Association guideline on BPH recommends finasteride or dutasteride for men with an enlarged prostate (volume greater than 30 mL) and moderate-to-severe lower urinary tract symptoms. The AUA guidelines are referenced through academic urology resources.

Sexual side effects are the most discussed adverse events. The FDA label reports that 3.8% of men taking finasteride 1 mg experienced decreased libido compared with 2.1% on placebo in key trials. A post-marketing concern about persistent sexual dysfunction after discontinuation (sometimes called post-finasteride syndrome) has been reported, though the causal relationship remains under study. A 2019 review in JAMA Dermatology examined the evidence base for persistent adverse effects. Patients should discuss the risk-benefit balance with their prescribing clinician before starting therapy.

Telehealth Prescribing of Finasteride in Iowa

Iowa allows telehealth prescribing of finasteride. Under Iowa Code Section 135.173 and the Iowa Board of Medicine's telehealth rules, a licensed physician or advanced practice provider may establish a valid patient-provider relationship via synchronous audio-video consultation and prescribe finasteride. Asynchronous (store-and-forward) consultations, where the patient submits photos and answers intake questions without a live video visit, are also permitted for non-controlled substances like finasteride under Iowa's current telehealth framework. The Iowa Board of Medicine's telehealth standards align with general interstate telehealth guidance reviewed by the Federation of State Medical Boards.

Several national telehealth platforms prescribe finasteride to Iowa residents. These typically charge a consultation fee, a prescription fee, or bundle both into a monthly subscription that includes the medication. Monthly subscription prices for finasteride through telehealth platforms range from $20 to $40 per month, which may include generic finasteride dispensed by a partner pharmacy or compounded topical finasteride from a 503A partner. Comparing the total monthly cost (consultation plus drug) with the cash-pay pharmacy price of $12 is worth doing before committing to a subscription model.

Iowa residents using out-of-state telehealth providers should confirm that the prescribing clinician holds an Iowa medical license or is registered under the Interstate Medical Licensure Compact. Iowa participates in the IMLC, which allows qualifying physicians licensed in member states to obtain expedited Iowa licensure. Prescriptions written by providers without a valid Iowa license are not legally valid for Iowa pharmacies. The IMLC's interstate compact framework is described at NCBI.

Iowa Discount Programs and Savings Strategies

Several practical options reduce finasteride costs for Iowa residents who are paying out of pocket.

GoodRx and similar discount programs. GoodRx, RxSaver, and NeedyMeds provide free discount cards accepted at most Iowa pharmacies. At Hy-Vee and CVS locations in Iowa, GoodRx codes consistently bring generic finasteride 1 mg (30 tablets) to $10 to $14. These are not insurance and do not count toward deductibles, but they cost nothing to use. NeedyMeds provides additional information on patient assistance options for low-income individuals.

Merck Patient Assistance Program. Merck offers a patient assistance program for Propecia for patients who meet income eligibility requirements. Iowa residents without insurance who fall below 200% of the federal poverty level may qualify. The application is submitted through the prescribing clinician's office or directly via Merck's patient assistance portal. Given that generic finasteride is available for $12 per month, the Merck program is most relevant for patients who specifically require the branded product. The FDA provides a list of manufacturer patient assistance resources.

90-day supplies. Requesting a 90-day supply at Costco Pharmacy (Iowa City, West Des Moines, Davenport) or through a mail-order pharmacy typically reduces the effective monthly cost below $10. Costco does not require a membership to use its pharmacy services.

Pill splitting (5 mg to 1 mg). Finasteride 5 mg tablets are cheaper per milligram than 1 mg tablets. Splitting a 5 mg tablet into five 1 mg doses is pharmacologically equivalent, since finasteride is an immediate-release tablet without special coating. This approach requires a pill cutter and consistent storage. A prescriber's endorsement or at minimum awareness is advisable before starting this strategy. Pharmacokinetic data supporting dose linearity are referenced in the published pharmacology literature indexed at PubMed.

Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs). Finasteride prescribed by a licensed clinician qualifies as a medical expense under IRS Publication 502 when the indication is BPH. For hair loss, the deductibility depends on whether the prescription is for a cosmetic versus medical purpose. Iowa residents with HSA or FSA accounts should consult a tax advisor on this specific question. Using pre-tax HSA dollars at a pharmacy that charges $12 per month brings the effective after-tax cost to roughly $8 to $10 for many Iowa earners.

Female Use, Pregnancy Warnings, and Iowa-Specific Prescribing Notes

Finasteride 1 mg (Propecia) is FDA-approved only for men. Women of childbearing potential must not take or handle crushed finasteride tablets because DHT inhibition during fetal development can cause ambiguous genitalia in male fetuses. The FDA classifies finasteride as Pregnancy Category X (legacy classification) based on animal teratogenicity data. The FDA teratogenicity data are documented in the prescribing information accessible at FDA's Drugs@FDA database.

Finasteride is used off-label in postmenopausal women with androgenetic alopecia in some dermatology practices. Iowa dermatologists and endocrinologists occasionally prescribe it for this indication. A 2020 systematic review in the Journal of the American Academy of Dermatology found evidence supporting finasteride's efficacy in postmenopausal women with AGA, though the trials were smaller and less standardized than the key male AGA studies. That review is indexed at PubMed. Off-label use in postmenopausal women in Iowa follows the same prescription requirements and pricing structures described above.

Iowa prescribers are not subject to any state-level restricted access programs for finasteride beyond the standard prescription requirement. No Iowa-specific REMS (Risk Evaluation and Mitigation Strategy) applies to finasteride. The FDA does not require a REMS for finasteride as of 2026. FDA REMS documentation is searchable at the FDA REMS database.

Comparing Finasteride to Alternatives in Iowa

Iowa residents considering hair loss treatment often ask how finasteride compares in cost to alternatives like minoxidil or dutasteride.

Minoxidil 5% topical solution is available over the counter in Iowa at approximately $8 per month, making it the only FDA-approved hair loss treatment cheaper than finasteride. Oral minoxidil (off-label, 2.5 to 5 mg daily) requires a prescription and costs roughly $15 to $20 per month cash-pay in Iowa. A 2022 review in the Journal of the American Academy of Dermatology compared oral minoxidil to finasteride efficacy data.

Dutasteride inhibits both type I and type II 5-alpha-reductase and is FDA-approved for BPH only, though it is widely used off-label for AGA. Generic dutasteride runs $20 to $40 per month in Iowa, roughly twice the cost of generic finasteride. A head-to-head trial published in the British Journal of Dermatology found dutasteride 0.5 mg produced greater hair count increases than finasteride 1 mg over 24 weeks, though with a broader side-effect profile. That comparative trial is indexed at PubMed.

Combination therapy with both finasteride and topical minoxidil is frequently used in clinical practice. The combined monthly cash-pay cost in Iowa runs approximately $20, making it one of the most cost-effective evidence-supported regimens for AGA. A randomized trial comparing combination therapy to monotherapy is indexed at PubMed.